Lactobacillus casei Zhang

Lactobacillus casei Zhang is a probiotic strain that produces bioactive compounds including bacteriocins and short-chain fatty acids. It enhances immune function through modulation of intestinal epithelial barrier integrity and stimulation of both innate and adaptive immune responses.

Origin & History

Lactobacillus casei Zhang is a specific probiotic strain isolated from traditional homemade koumiss, a fermented mare's milk from Inner Mongolia, China. It is a gram-positive lactic acid bacterium produced through standard microbiological fermentation, where it reaches high concentrations (10^8–10^9 CFU/ml) while producing L-lactic acid.

Historical & Cultural Context

This strain was isolated from traditional koumiss, a fermented mare's milk beverage historically consumed by Mongolian nomads in Inner Mongolia for its nutritional and probiotic value. However, specific traditional medicinal use for the Zhang strain itself is not documented beyond its modern isolation.

Health Benefits

["\u2022 May enhance natural and acquired immunity, based on preclinical evidence from in vitro and mouse models [1].", "\u2022 Demonstrates strong adherence to human intestinal epithelial cells (HT-29) in vitro, suggesting potential for gut colonization and barrier support [1].", "\u2022 Shows high tolerance to gastrointestinal conditions, surviving low pH (2.5) and bile (1.5% oxgall) in lab settings, indicating potential for survival during transit [1].", "\u2022 May antagonize pathogenic bacteria like Escherichia coli, according to in vitro studies [1].", "\u2022 Exhibits cholesterol-removing capabilities from media in a laboratory setting, though human effects are unconfirmed [1]."]

How It Works

Lactobacillus casei Zhang adheres strongly to intestinal epithelial cells via surface proteins, enhancing tight junction integrity and barrier function. The strain produces bacteriocins and metabolites that modulate immune cell activity, stimulating both Th1 and Th2 immune responses. Its bioactive compounds also influence cytokine production pathways, promoting balanced inflammatory responses in gut-associated lymphoid tissue.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses have been conducted specifically on Lactobacillus casei Zhang. The available evidence is limited to preclinical research, including in vitro and mouse models, which explored its stress tolerance and immune-modulating properties (PMID: 19564469, 32522964, 36436758).

Clinical Summary

Current evidence for Lactobacillus casei Zhang is primarily limited to preclinical studies including in vitro cell culture models and mouse studies. Research demonstrates strong adherence to human intestinal epithelial cells (HT-29 cell line) and immune enhancement in animal models. However, human clinical trials are lacking, making it difficult to establish definitive therapeutic benefits in humans. The existing preclinical data suggests potential for immune support and gut health, but human studies are needed to confirm efficacy and optimal dosing.

Nutritional Profile

Lactobacillus casei Zhang is a probiotic bacterium, not a traditional nutrient source, so macronutrient content is negligible in supplemental doses (typically 1×10⁸ to 1×10¹⁰ CFU per serving). Its bioactive contributions include cell wall components such as peptidoglycans, lipoteichoic acids, and surface layer proteins (S-layer proteins) that interact with host toll-like receptors (TLR-2, TLR-4). It produces short-chain fatty acids (SCFAs) including acetate and lactate as fermentation byproducts, contributing to colonocyte energy metabolism. Exopolysaccharides (EPS) produced by this strain have documented immunomodulatory activity. The strain also synthesizes B-vitamins during fermentation, particularly folate (B9) and riboflavin (B2), in small but biologically relevant quantities. Bioavailability of its probiotic effects is contingent on viability at delivery — this strain demonstrates notable acid tolerance at pH 2.5 and bile salt resistance at 1.5% oxgall, supporting meaningful gut colonization and transient residence in the intestinal epithelium.

Preparation & Dosage

No clinically studied dosage ranges for Lactobacillus casei Zhang are available, as human trials have not been conducted. Preclinical studies used concentrations of 10^8–10^9 CFU/ml in culture, but no standardized human dose has been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Lactobacillus casei Zhang pairs strongly with prebiotic fibers such as inulin and fructooligosaccharides (FOS), which serve as selective fermentation substrates that significantly increase SCFA output and extend the strain's colonization window via the prebiotic-probiotic (synbiotic) mechanism. Pairing with Bifidobacterium longum creates complementary immune modulation — L. casei Zhang primarily stimulates Th1 cytokine pathways (IL-12, IFN-γ), while B. longum reinforces mucosal IgA secretion, together providing broader mucosal and systemic immune coverage. Additionally, vitamin D3 (cholecalciferol, 1000–2000 IU) synergizes with this strain by upregulating tight junction proteins (claudin-1, occludin) through VDR signaling in intestinal epithelial cells, complementing the strain's own barrier-support activity and enhancing overall gut barrier integrity.

Safety & Interactions

Lactobacillus casei Zhang is generally considered safe for healthy individuals as it belongs to a well-studied probiotic species. However, individuals with severe immunocompromise or critical illness should consult healthcare providers before use due to rare reports of bacteremia with probiotic strains. No specific drug interactions have been documented, though it may theoretically affect antibiotic efficacy if taken simultaneously. Safety during pregnancy and lactation has not been specifically established for this particular strain, though L. casei species are generally considered safe in these populations.